If a drug could be said to be having a blockbuster moment, then 2023 is as much Ozempic's year as it is Pedro Pascal's.
This article is being processed for speech. This might take a few seconds. You can listen to other articles in the mean time.
Your playlist has ended. Why not listen to the morning edition ?